Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Marion Mafham, Jennifer Bell, et al.
The Lancet (2020) Vol. 396, Iss. 10259, pp. 1345-1352
Open Access | Times Cited: 701

Showing 1-25 of 701 citing articles:

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
Hongchao Pan, Richárd Pető, Ana‐Maria Henao‐Restrepo, et al.
New England Journal of Medicine (2020) Vol. 384, Iss. 6, pp. 497-511
Open Access | Times Cited: 2497
Severe Covid-19
David Berlin, Roy M. Gulick, Fernando J. Martínez
New England Journal of Medicine (2020) Vol. 383, Iss. 25, pp. 2451-2460
Closed Access | Times Cited: 1390
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 397, Iss. 10285, pp. 1637-1645
Open Access | Times Cited: 1016
Drug treatments for covid-19: living systematic review and network meta-analysis
Reed Siemieniuk, Jessica Bartoszko, Dena Zeraatkar, et al.
BMJ (2020), pp. m2980-m2980
Open Access | Times Cited: 796
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi, et al.
The Lancet (2021) Vol. 397, Iss. 10274, pp. 605-612
Open Access | Times Cited: 531
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial results
Hongchao Pan, Richard Peto, Quarraisha Abdool Karim, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 431
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2022) Vol. 399, Iss. 10325, pp. 665-676
Open Access | Times Cited: 354
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial
Peter Horby, Guilherme Pessoa-Amorim, Leon Peto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 302
An update on COVID-19 pandemic: the epidemiology, pathogenesis, prevention and treatment strategies
Hin Fung Tsang, Lawrence Chan, William C. Cho, et al.
Expert Review of Anti-infective Therapy (2020) Vol. 19, Iss. 7, pp. 877-888
Closed Access | Times Cited: 286
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2021) Vol. 399, Iss. 10320, pp. 143-151
Open Access | Times Cited: 257
First and second waves of coronavirus disease-19: A comparative study in hospitalized patients in Reus, Spain
Simona Iftimie, Ana F. López‐Azcona, Immaculada Vallverdú, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0248029-e0248029
Open Access | Times Cited: 255
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Obbina Abani, Ali Abbas, Fatima Abbas, et al.
The Lancet (2022) Vol. 400, Iss. 10349, pp. 359-368
Open Access | Times Cited: 254
Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19
Perrine Janiaud, Cathrine Axfors, Andreas M. Schmitt, et al.
JAMA (2021) Vol. 325, Iss. 12, pp. 1185-1185
Open Access | Times Cited: 227
Management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline
James D. Chalmers, Megan Crichton, Pieter Goeminne, et al.
European Respiratory Journal (2021) Vol. 57, Iss. 4, pp. 2100048-2100048
Open Access | Times Cited: 201
Antiviral drug discovery: preparing for the next pandemic
Catherine S. Adamson, Kelly Chibale, Rebecca J. M. Goss, et al.
Chemical Society Reviews (2021) Vol. 50, Iss. 6, pp. 3647-3655
Open Access | Times Cited: 193
Overview of SARS-CoV-2 infection in adults living with HIV
Juan Ambrosioni, José Luís Blanco, Juliana Reyes‐Urueña, et al.
The Lancet HIV (2021) Vol. 8, Iss. 5, pp. e294-e305
Open Access | Times Cited: 176
The interplay between HIV and COVID-19: summary of the data and responses to date
Lillian B. Brown, Matthew A. Spinelli, Monica Gandhi
Current Opinion in HIV and AIDS (2020) Vol. 16, Iss. 1, pp. 63-73
Open Access | Times Cited: 173
Colchicine in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1419-1426
Open Access | Times Cited: 171
Identification of existing pharmaceuticals and herbal medicines as inhibitors of SARS-CoV-2 infection
Jia-Tsrong Jan, Ting-Jen Rachel Cheng, Yu-Pu Juang, et al.
Proceedings of the National Academy of Sciences (2021) Vol. 118, Iss. 5
Open Access | Times Cited: 169
The development of COVID-19 treatment
Yongliang Yuan, Baihai Jiao, Lili Qu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 150
ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2—care pathways, treatment, and follow-up
Colin Baigent, Stephan Windecker, Daniele Andreini, et al.
European Heart Journal (2021) Vol. 43, Iss. 11, pp. 1059-1103
Open Access | Times Cited: 147
Mortality in patients admitted to intensive care with COVID‐19: an updated systematic review and meta‐analysis of observational studies
R. A. Armstrong, Andrew D. Kane, E. Kursumovic, et al.
Anaesthesia (2021) Vol. 76, Iss. 4, pp. 537-548
Open Access | Times Cited: 145
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Peter Horby, Marion Mafham, Leon Peto, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 139
The Drug Repurposing for COVID-19 Clinical Trials Provide Very Effective Therapeutic Combinations: Lessons Learned From Major Clinical Studies
Chiranjib Chakraborty, Ashish Ranjan Sharma, Manojit Bhattacharya, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 136
Effect of Early Treatment With Hydroxychloroquine or Lopinavir and Ritonavir on Risk of Hospitalization Among Patients With COVID-19
Gilmar Reis, Eduardo Augusto dos Santos Moreira Silva, Daniela Carla Medeiros Silva, et al.
JAMA Network Open (2021) Vol. 4, Iss. 4, pp. e216468-e216468
Open Access | Times Cited: 127
Page 1 - Next Page

Scroll to top